Clinical trial
Intralesional Injections of Triamcinolone for Acne Vulgaris
NCT06170593 is registered in ClinicalTrials.gov with ACOM Labs as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intralesional Injections of Triamcinolone for Acne Vulgaris
- Lead sponsor
- ACOM Labs
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 15, 2022
- Completion date
- February 14, 2023
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.